Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy H J Goodship

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Clinical Kidney Journal|September 29, 2015
Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?Troels Ring, Birgitte Bang Pedersen, Giedrius Salkus, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
Anodipsia nervosa a variant of anorexia in patients with end-stage renal diseasePhillip Hampton, Kenneth A Graham, Mairi Millar, et al.
Human Mutation|November 11, 2005
An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutationsRebecca E Saunders, Timothy H J Goodship, Peter F Zipfel, et al.
Nephron Extra|October 29, 2013
Prevalence in the General Population of a CFH Sequence Variant Associated with Atypical Haemolytic Uraemic Syndrome in an Extensive Family from Southwest EnglandAlexander J Hamilton, Carl B A Lyons, Timothy H J Goodship, et al.
Immunobiology|June 4, 2015
Patient stratification and therapy in atypical haemolytic uraemic syndrome (aHUS)Edwin Wong, Rachel Challis, Neil Sheerin, et al.
Clinical Kidney Journal|June 20, 2014
Atypical haemolytic uraemic syndrome associated with a <i>CD46</i> mutation triggered by <i>Shigella flexneri.</i>Vicky Brocklebank, Edwin K S Wong, Rick Fielding, et al.
Molecular Immunology|January 24, 2009
Is complement factor H a susceptibility factor for IgA nephropathy?Matthew Edey, Lisa Strain, Roy Ward, et al.
Kidney International|June 26, 2002
Effects of feeding on albumin synthesis in hypoalbuminemic hemodialysis patientsJonathan D Louden, Kim Bartlett, David Reaich, et al.
Pediatrics|May 6, 2015
Case report: Benefits and challenges of long-term eculizumab in atypical hemolytic uremic syndromeNoelle Cullinan, Kathleen Mary Gorman, Michael Riordan, et al.
Molecular Immunology|October 10, 2006
Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndromeM Kathryn Liszewski, Marilyn K Leung, Barbara Schraml, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Clinical Kidney Journal|September 29, 2015
Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?Troels Ring, Birgitte Bang Pedersen, Giedrius Salkus, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 2002
Anodipsia nervosa a variant of anorexia in patients with end-stage renal diseasePhillip Hampton, Kenneth A Graham, Mairi Millar, et al.
Human Mutation|November 11, 2005
An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutationsRebecca E Saunders, Timothy H J Goodship, Peter F Zipfel, et al.
Nephron Extra|October 29, 2013
Prevalence in the General Population of a CFH Sequence Variant Associated with Atypical Haemolytic Uraemic Syndrome in an Extensive Family from Southwest EnglandAlexander J Hamilton, Carl B A Lyons, Timothy H J Goodship, et al.
Immunobiology|June 4, 2015
Patient stratification and therapy in atypical haemolytic uraemic syndrome (aHUS)Edwin Wong, Rachel Challis, Neil Sheerin, et al.
Clinical Kidney Journal|June 20, 2014
Atypical haemolytic uraemic syndrome associated with a <i>CD46</i> mutation triggered by <i>Shigella flexneri.</i>Vicky Brocklebank, Edwin K S Wong, Rick Fielding, et al.
Molecular Immunology|January 24, 2009
Is complement factor H a susceptibility factor for IgA nephropathy?Matthew Edey, Lisa Strain, Roy Ward, et al.
Kidney International|June 26, 2002
Effects of feeding on albumin synthesis in hypoalbuminemic hemodialysis patientsJonathan D Louden, Kim Bartlett, David Reaich, et al.
Pediatrics|May 6, 2015
Case report: Benefits and challenges of long-term eculizumab in atypical hemolytic uremic syndromeNoelle Cullinan, Kathleen Mary Gorman, Michael Riordan, et al.
Molecular Immunology|October 10, 2006
Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndromeM Kathryn Liszewski, Marilyn K Leung, Barbara Schraml, et al.
Pageof 8